 TORONTO , Sept. 9, 2022 PRNewswire - Braxia Scientific Corp. Braxia Scientific, or the Company, CSE: BRAX OTC: BRAXF FWB: 4960, a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, is pleased to announce its participation at the H.C. 